Outcome of low dose daily versus standard alternate day prednisolone for frequent relapse nephrotic syndrome in children

Read full text Summarise with VIRAT
Authors: M. Masum Billah, Tanjila Afrin, Sadia Shamsad, Anjuman Ara Khatun, M. Reaz Uddin, M. Anwar Hossain Khan, A B M Mahbub Ul Alam
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Nephrotic syndrome is a common chronic glomerular disorder in children, with frequent relapses causing significant clinical and psychosocial burden. Prednisolone remains the cornerstone of therapy, typically administered on an alternate-day schedule for maintenance. However, low daily-dose regimens may improve relapse control with fewer adverse effects, particularly in resource-limited settings. Methods: This quasi-experimental study included 72 children aged 2-12 years with FRNS treated at the National Institute of Kidney Diseases and Urology, Dhaka, between August 2022 and August 2024. Participants received either daily low-dose prednisolone (0.2 mg/kg; Group A, n=31) or alternate-day prednisolone (0.5 mg/kg; Group B, n=32) for six months. Clinical features, anthropometric measurements, laboratory findings, relapse frequency, and steroid-related adverse effects were assessed at baseline, 3 months, and 6 months. Data were analyzed using independent T-tests and chi-square tests, with p

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Adrenal Hormones and Disorders

Publication details

Journal / source
International Journal of Contemporary Pediatrics
Volume
13
Issue
4
Pages
576–583
Publication date
25 March 2026
Language
EN